Acetylsalicylic acid Completed Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00691704Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy